Stock Track | Dentsply Sirona Plummets 5% on Disappointing Earnings, Analyst Downgrades

Stock Track

Mar 01, 2025

Dentsply Sirona (XRAY) shares plunged 5.07% on Friday following the company's Q4 2024 earnings report, which showed a wider net loss of $910 million and earnings per share of -$4.48 that missed analyst expectations. The dental equipment maker's revenue also declined 4.3% year-over-year.

In the wake of the weak results, several analysts downgraded their ratings and price targets on XRAY. Bank of America lowered its target to $19 citing limited visibility, while Wells Fargo cut its target to $19 as well citing the company's cost pressures. Barrington lowered its target but maintained an Outperform rating.

Analysts point to ongoing market challenges and headwinds impacting Dentsply Sirona's performance. The company is struggling with rising costs and competitive pressures in the dental equipment market. Looking ahead, slowing revenue growth forecasts suggest these issues could persist.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1184404572"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184404572\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184404572?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-01 02:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184404572","market":"us","top_or_hot":-1,"title":"Stock Track | Dentsply Sirona Plummets 5% on Disappointing Earnings, Analyst Downgrades","media":"Stock Track","content":"<p>Dentsply Sirona (XRAY) shares plunged 5.07% on Friday following the company's Q4 2024 earnings report, which showed a wider net loss of $910 million and earnings per share of -$4.48 that missed analyst expectations. The dental equipment maker's revenue also declined 4.3% year-over-year.</p>\n\n<p>In the wake of the weak results, several analysts downgraded their ratings and price targets on XRAY. Bank of America lowered its target to $19 citing limited visibility, while Wells Fargo cut its target to $19 as well citing the company's cost pressures. Barrington lowered its target but maintained an Outperform rating.</p>\n\n<p>Analysts point to ongoing market challenges and headwinds impacting Dentsply Sirona's performance. The company is struggling with rising costs and competitive pressures in the dental equipment market. Looking ahead, slowing revenue growth forecasts suggest these issues could persist.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Dentsply Sirona Plummets 5% on Disappointing Earnings, Analyst Downgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Dentsply Sirona Plummets 5% on Disappointing Earnings, Analyst Downgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-01 02:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dentsply Sirona (XRAY) shares plunged 5.07% on Friday following the company's Q4 2024 earnings report, which showed a wider net loss of $910 million and earnings per share of -$4.48 that missed analyst expectations. The dental equipment maker's revenue also declined 4.3% year-over-year.</p>\n\n<p>In the wake of the weak results, several analysts downgraded their ratings and price targets on XRAY. Bank of America lowered its target to $19 citing limited visibility, while Wells Fargo cut its target to $19 as well citing the company's cost pressures. Barrington lowered its target but maintained an Outperform rating.</p>\n\n<p>Analysts point to ongoing market challenges and headwinds impacting Dentsply Sirona's performance. The company is struggling with rising costs and competitive pressures in the dental equipment market. Looking ahead, slowing revenue growth forecasts suggest these issues could persist.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XRAY","symbol_name":"登士柏国际","start_time":0,"source_url":"","article_id":"1184404572","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184404572","pubTimestamp":1740768030,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Dentsply Sirona  shares plunged 5.07% on Friday following the company's Q4 2024 earnings report, which showed a wider net loss of $910 million and earnings per share of -$4.48 that missed analyst expectations. The dental equipment maker's revenue also declined 4.3% year-over-year.In the wake of the weak results, several analysts downgraded their ratings and price targets on XRAY. Bank of America lowered its target to $19 citing limited visibility, while Wells Fargo cut its target to $19 as well ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XRAY":"登士柏国际"},"translate_title":"股票追踪Dentsply Sirona因盈利令人失望和分析师下调评级而暴跌5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XRAY":1},"content_text":"Dentsply Sirona (XRAY) shares plunged 5.07% on Friday following the company's Q4 2024 earnings report, which showed a wider net loss of $910 million and earnings per share of -$4.48 that missed analyst expectations. The dental equipment maker's revenue also declined 4.3% year-over-year.\nIn the wake of the weak results, several analysts downgraded their ratings and price targets on XRAY. Bank of America lowered its target to $19 citing limited visibility, while Wells Fargo cut its target to $19 as well citing the company's cost pressures. Barrington lowered its target but maintained an Outperform rating.\nAnalysts point to ongoing market challenges and headwinds impacting Dentsply Sirona's performance. The company is struggling with rising costs and competitive pressures in the dental equipment market. Looking ahead, slowing revenue growth forecasts suggest these issues could persist.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}